Cardiovascular Disease Doctors in Russellville, AR Accepting Medicare

5 Cardiovascular Disease doctors found. Showing 1 - 5

Stephen C. Dobratz, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2205 W Main St, Russellville, AR 72801 Phone: 479-968-4311    Fax: 479-968-4399

Abdul Hakeem, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1808 W Main St, Russellville, AR 72801 Phone: 479-968-2841    Fax: 479-964-5910

Sheharyar Ali, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2205 W Main St, Russellville, AR 72801 Phone: 479-968-4311    Fax: 479-968-4399

Dr. Shuja Rasool, M.D Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2205 W Main St, Russellville, AR 72801 Phone: 479-968-4311    Fax: 479-968-4399

Dai-yuan Wang, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2205 W Main St, Russellville, AR 72801 Phone: 479-968-4311    Fax: 479-968-4399

News Archive

New findings on effects of epilepsy on mother and child

New research pertaining to the latest findings on the effects of epilepsy on both the mother and child were presented at the American Epilepsy Society's 67th Annual Meeting in Washington DC. These studies explore folic acid use, the effect of surgery with intractable focal epilepsy, and antiepileptic drug exposure during breastfeeding.

Many mouth cancers found too late

Worldwide, more than 500,000 new cases of cancer of the mouth are diagnosed each year.

Oragenics enters into Common Stock Purchase Agreement with KFLP

On July 5, 2010, Oragenics, Inc. entered into a Common Stock Purchase Agreement with the Koski Family Limited Partnership ("KFLP"), an accredited investor and the Company's largest shareholder. The entering into of the Agreement was approved by the Company's disinterested directors.

VGTI, OHSU's new vaccine candidate may fight against HIV

Research conducted at Oregon Health & Science University's Vaccine and Gene Therapy Institute has developed a vaccine candidate in non-human primates that may eventually lead to a vaccine against Human Immunodeficiency Virus.

HIV prevalence in Botswana is 17.1%, President Mogae says

HIV prevalence in Botswana is 17.1%, lower than figures previously reported by UNAIDS, Botswana President Festus Mogae said Monday, Xinhua/People's Daily reports.

Read more Medical News

› Verified 7 days ago